Brownstein S L, Hopson R C, Martins J B, Aschoff A M, Olshansky B, Constantin L, Kienzle M G
Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City 52242.
Am J Cardiol. 1988 May 1;61(13):1037-41. doi: 10.1016/0002-9149(88)90121-x.
In some patients with documented atrioventricular (AV) nodal supraventricular tachycardia (SVT), the arrhythmia is not inducible during a standard stimulation protocol. In these patients the level of sympathetic activity may be an important factor. This study evaluates the influence of isoproterenol on anterograde and retrograde pathway properties in patients with AV nodal SVT and the mechanism by which this SVT is facilitated. Group 1 consisted of 8 consecutive patients, ages 23 to 85 years (mean +/- standard error, 57 +/- 8) who had no inducible AV nodal SVT during electrophysiologic testing until isoproterenol (0.5 to 3.0 micrograms/min) was infused. These patients were compared with 6 patients in the same age range (45 to 78 years, mean +/- standard error, 64 +/- 5) who had inducible AV nodal SVT without isoproterenol and who comprised group 2. In comparing group 1 (before isoproterenol) with group 2, there was no significant difference in the refractory periods of the anterograde slow and fast pathways, although the anterograde block cycle length was longer in group 1 patients (421 +/- 18 vs 362 +/- 14 ms, p less than 0.05). The retrograde block cycle length was also longer in 7 of the 8 group 1 (before isoproterenol) patients in whom it could be measured versus those in group 2 (411 +/- 14 vs 318 +/- 27 ms, p less than 0.05). During isoproterenol, the anterograde and retrograde block cycle lengths in group 1 were not different from group 2. Therefore, AV nodal SVT may not be inducible in some patients during routine electrophysiologic testing.(ABSTRACT TRUNCATED AT 250 WORDS)
在一些记录有房室(AV)结性室上性心动过速(SVT)的患者中,在标准刺激方案期间心律失常不可诱发。在这些患者中,交感神经活动水平可能是一个重要因素。本研究评估了异丙肾上腺素对AV结性SVT患者顺行和逆行传导途径特性的影响以及促进这种SVT的机制。第1组由8例连续患者组成,年龄23至85岁(平均±标准误,57±8),在电生理检查期间直至输注异丙肾上腺素(0.5至3.0微克/分钟)时均未诱发AV结性SVT。将这些患者与6例年龄范围相同(45至78岁,平均±标准误,64±5)的患者进行比较,后者在未使用异丙肾上腺素时可诱发AV结性SVT,组成第2组。在比较第1组(使用异丙肾上腺素前)和第2组时,顺行慢径和快径的不应期无显著差异,尽管第1组患者的顺行阻滞周期长度更长(421±18对362±14毫秒,p<0.05)。在8例第1组(使用异丙肾上腺素前)患者中有7例可测量其逆行阻滞周期长度,与第2组相比也更长(411±14对318±27毫秒,p<0.05)。在使用异丙肾上腺素期间,第1组的顺行和逆行阻滞周期长度与第2组无差异。因此,在一些患者的常规电生理检查期间可能无法诱发AV结性SVT。(摘要截断于250字)